Exhibit 32.1
Certification Pursuant to 18 U.S.C. Section 1350
In connection with the annual report of Marinus Pharmaceuticals, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned, in the capacities and on the date indicated below, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:
Date: March 9, 2023 | /s/ Scott Braunstein |
| Chief Executive Officer and Director |
| (Principal Executive Officer) |
| |
Date: March 9, 2023 | /s/ Steven Pfanstiel |
| Chief Operating Officer, Chief Financial Officer and Treasurer (Principal Financial and |
| Accounting Officer) |